Cosmetic use of botulinum toxin in the upper face

Operative Techniques in Otolaryngology - Head and Neck Surgery

Volumn 18, Issue 3, 2007, Pages 248-253

  Bassichis, Benjamin A ^a  

^a Advanced Facial Plastic Surgery Center   (United States)

Author keywords

Botox; Botox Cosmetic; Botulinum toxin type A; Clostridium botulinum; Facial injection; Facial rejuvenation; Minimally invasive procedure

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; APRACLONIDINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; EYE DROPS; NAPHAZOLINE; PHENYLEPHRINE; QUININE; UNCLASSIFIED DRUG; VISTABEX; VITABEL;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BREAST FEEDING; DIPLOPIA; DOSE TIME EFFECT RELATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG SAFETY; DRY EYE; EATON LAMBERT SYNDROME; ECCHYMOSIS; EPIPHORA; ESTHETIC SURGERY; EYELID DISEASE; FACE ASYMMETRY; FLU LIKE SYNDROME; HUMAN; INJECTION SITE PAIN; INJECTION SITE REACTION; MINIMALLY INVASIVE SURGERY; MYASTHENIA GRAVIS; PARALYSIS; PATIENT SATISFACTION; PREGNANCY; PRIORITY JOURNAL; PTOSIS; RECOMMENDED DRUG DOSE; RHYTIDOPLASTY; SWELLING;

EID: 36248973804     PISSN: 10431810     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otot.2007.08.004     Document Type: Article

References (34)

1. Carruthers A., and Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 24 (1998) 1189-1194
2. Guerrissi J., and Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg 39 (1997) 447-453
3. Blitzer A., Binder W.J., Aviv J.E., et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 123 (1997) 389-392
4. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 103 (1999) 701-713
5. Dayan S.H., and Bassichis B.A. Evaluation of the patient for cosmetic Botox injections. (review). Facial Plast Surg Clin North Am 11 (2003) 349-358
6. Pribitkin E.A., Greco T.M., Goode R.L., et al. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg 123 (1997) 321-326
7. Carruthers J.A., Lowe N.J., Menter M.A., et al. A multicentre, double-blind, randomized, placebo-controlled study of efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46 (2002) 840-849
8. BOTOX Cosmetic (2002), Allergan, Irvine, CA [package insert]
9. Klein A.W. Dilution and storage of botulinum toxin. Dermatol Surg 24 (1998) 1179-1180
10. Hexsel D.M., de Almeida A.T., Rutowitsch M., et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted in 6 consecutive weeks. Dermatol Surg 29 (2003) 523-529
11. Huang W., Foster J.A., and Rogachefsky A.S. Pharmacology of botulinum toxin. J Am Acad Dermatol 43 (2000) 249-259
12. Alam M., Dover J.S., and Arndt K.A. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: A double-blind, randomized controlled trial. Arch Dermatol 138 (2002) 510-514
13. Carruthers J., Fagien S., Matarasso S.L., et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114 (2004) 1S-22S
14. Carruthers A., Carruthers J., and Cohen J. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter?. Dermatol Surg Volume 33 (2007) S97
15. Carruthers A., and Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 31 (2005) 1297-1303
16. Carruthers A., and Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 20 (2001) 71-84
17. Klein A.W. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg 29 (2003) 549-556
18. Hsu T.S.J., Dover J.S., and Arndt K.A. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 140 (2004) 1351-1354
19. Hexsal D.M., de Almeida A.T., Rutowitsch M., et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg 29 (2003) 523-529
20. Bassichis B.A., and Thomas J.R. The use of Botox to treat glabellar rhytids. Facial Plast Surg Clin North Am 13 (2005) 11-14 (review)
21. Pribitkin E.A., Greco T.M., Goode R.L., et al. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg 123 (1997) 321-326
22. Carruthers A., Carruthers J., and Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 31 (2005) 414-422
23. Carruthers A., and Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg 33 (2007) S26-S31
24. Ahn M.S., Catten M., and Maas C.S. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 105 (2000) 1129-1135 discussion 1136-1139
25. Huilgo S.C., Carruthers A., and Carruthers J.D. Raising eyebrows with botulinum toxin. Dermatol Surg 25 (1999) 373-375
26. Huang W., Rogachefsky A.S., and Foster J.A. Brow lift with botulinum toxin. Dermatol Surg 26 (2000) 55-60
27. Spencer J.M., Gordon M., and Goldberg D.J. Botulinum B treatment of the glabellar and frontalis regions: A dose response analysis. J Cosmet Laser Ther 4 (2002) 19-23
28. Frankel A.S. Botox for rejuvenation of the periorbital region. Facial Plast Surg 15 (1999) 255-262
29. Matarasso S.L., and Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg 108 (2001) 208-214 discussion 215-217
30. Lowe N.J., Lask G., Yamauchi P., et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patient with crow's feet. J Am Acad Dermatol 47 (2002) 834-840
31. Balikian R.V., and Zimbler M.S. Primary and adjunctive uses of Botulinum Toxin Type A in the periorbital region. Facial Plast Surg Clin North Am 13 (2005) 583-590 (review)
32. Cote T.R., Mohan A.K., Polder J.A., et al. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 53 (2005) 407-415
33. Vartanian A.J., and Dayan S.H. Complications of botulinum toxin A use in facial rejuvenation. (review). Facial Plast Surg Clin North Am 13 (2005) 1-10
34. Carruthers A., and Carruthers J. Botulinum toxin type A. J Am Acad Dermatol 53 (2005) 284-290